이상반응 보고
| VAERS ID | 2167359 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | |
| 예방접종 횟수 | 3 |
| 접종일 | 2022-01-25 |
| 발병일 | 2022-01-29 |
| 상태 | 사망 |
증상
- 심근 경색증(Myocardial infarction)
- 심장혈관조영술(Angiocardiogram)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
Test Name: coronary anvasospasm or giogram; Result Unstructured Data: Test Result:showed possibly vasospasm or dissection
증상 상세
Myocardial infarction; This is a spontaneous report received from a contactable consumer from Regulatory Authority.
Regulatory number: AEFI-A-063691 (RA Case Number).
A 31-year-old female patient received BNT162B2 (COMIRNATY; lot number and expiration date were not reported), via an unspecified route of administration on 25Jan2022 as dose 3 (booster), single for COVID-19 immunization.
The patient's relevant medical history and concomitant medications were not reported.
Vaccination history included: COMIRNATY (first dose), for COVID-19 immunization; COMIRNATY (second dose), for COVID-19 immunization.
The following information was reported: MYOCARDIAL INFARCTION (death) with onset 29Jan2022 19:00, outcome "fatal", described as "Myocardial infarction".
It was reported that patient was resuscitated, and coronary angiogram showed possibly vasospasm or dissection.
Ultimately, unclear etiology for cardiac arrest.
Patient died from cardiac failure due to myocardial infarction.
The patient date of death was unknown.
The reported cause of death was myocardial infarction.
It was not reported if an autopsy was performed.
No follow-up attempts are possible; information about lot/batch number cannot be obtained.
No further information is expected.
; Reported Cause(s) of Death: Myocardial infarction